
Regulatory decisions & notices (complementary medicines)
Complementary medicines decisions
- Complementary medicines: Cancellations from the ARTG following compliance review
Lists of complementary medicines cancelled from the Australian Register of Therapeutic Goods
Complementary medicine notices
Older, revoked and superseded notices are available in the TGA Internet site archive.
2017
- Updates to the Permissible Ingredients Determination for listed medicines
21 April 2017: On 21 April 2017 an updated version of the Therapeutic Goods (Permissible Ingredients) Determination was registered on the Federal Register of Legislation - Permissible Ingredients Determination: Forecast of updates
4 April 2017: Anticipated timeframe for updates to the Permissible Ingredients Determination in 2017
2016
- Permissible Ingredients Determination: Frequently asked questions
6 January 2016 : On 1 January 2016, a new legislative instrument under section 26BB of the Therapeutic Goods Act 1989, the Therapeutic Goods (Permissible Ingredients) Determination was introduced
2015
- Required Advisory Statements for Medicine Labels No. 3
11 November 2015: Updated edition of the Medicines Advisory Statements Specification is proposed to be registered on the Federal Register of Legislative Instruments on or shortly after 12 December 2015 - Marketing complementary medicines with soft gel capsules for children
29 June 2015 : Soft gel capsules may pose a choking hazard for children, especially those aged under five years - New ingredient names available for metal amino acid chelates
6 March 2015 : Specific Australian Approved Names (AANs) for metal amino acid chelates have been made available for use in the Electronic Listing Facility (ELF)
2013
- Compositional guideline: Deer velvet antler powder - amendment
28 March 2013: The acceptance criterion for 'Ash' has been amended to 15.0 - 47.6% (dried basis)
